|?|| (A;A) (A;G) (G;G) ||28|
] Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy
[PMID 20019880] Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration.
[PMID 20959405] The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.
[PMID 23030506] SINGLE NUCLEOTIDE POLYMORPHISM AND SERUM LEVELS OF VEGFR2 ARE ASSOCIATED WITH AGE RELATED MACULAR DEGENERATION
[PMID 25139485] Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer